BridgeMD
New treatment option for Muscle-Invasive Bladder Carcinoma
Official title Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers
ClinicalTrials.gov ID: NCT06537960
What this study is testing
- What it's testing
- The goal of this study is to demonstrate a significant gain in sensitivity versus surgical curage (extended pelvic) for initial lymph node staging of late FDG-PET images (2.5 hours) versus standard images (1 hour), analyzed by side (right iliac/left iliac areas in Patients with muscle-invasive bladder tumor (MIBT) (≥pT2) referred for FDG-PET in the nuclear medicine department of Hôpital Foch as part of their initial extension workup. Before performing 18FDG PET-CT, the operator checks that the patient has fasted for at least 6 hours and that blood glucose levels are below 11 mmol/l.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient 18 years of age or older,
- With histologically proven muscle-invasive bladder cancer (≥pT2) at endoscopic bladder resection,
- Scheduled to undergo 18FDG PET-CT in the nuclear medicine department at Hôpital Foch,
- Having signed a consent form,
- Affiliated to a health insurance scheme.
You likely can't join if
- Patient with a history of pelvic or genitourinary cancer,
- Patient with known metastatic disease,
- Patient with a contraindication to 18FDG PET-CT,
- Pregnant or breast-feeding woman,
- Patient deprived of liberty or under guardianship.
The study team makes the final eligibility decision.
Where it's taking place
- Suresnes, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Suresnes, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.